Evidence map›Paper›PMID 30296268›Full record

ArticlePLoS neglected tropical diseases2018

Ligand binding properties of two Brugia malayi fatty acid and retinol (FAR) binding proteins and their vaccine efficacies against challenge infection in gerbils.

Bin Zhan, Sridhar Arumugam, Malcolm W Kennedy, Nancy Tricoche, Lu-Yun Lian, Oluwatoyin A Asojo, Sasisekhar Bennuru, Maria Elena Bottazzi, Peter J Hotez, Sara Lustigman and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. A secreted fatty acid- and retinol- binding protein frombioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Parasitology · 2021
    Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Bin ZhanTexas Children's Hospital Center for Vaccine Development, Departments of Pediatric Tropical Medicine and Molecular Virology and Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, United States of America.
Sridhar ArumugamDepartment of Pathobiological Sciences, LSU School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA, United States of America.
Malcolm W KennedyInstitute of Biodiversity Animal Health and Comparative Medicine, Graham Kerr Building, University of Glasgow, Glasgow, Scotland, UK.
Nancy TricocheLaboratory of Molecular Parasitology, Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY, United States of America.
Lu-Yun LianNMR Centre for Structural Biology, University of Liverpool, Crown Street, Liverpool, United Kingdom.
Oluwatoyin A AsojoTexas Children's Hospital Center for Vaccine Development, Departments of Pediatric Tropical Medicine and Molecular Virology and Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, United States of America.
Sasisekhar BennuruLaboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, United States of America.
Maria Elena BottazziTexas Children's Hospital Center for Vaccine Development, Departments of Pediatric Tropical Medicine and Molecular Virology and Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, United States of America.
Peter J HotezTexas Children's Hospital Center for Vaccine Development, Departments of Pediatric Tropical Medicine and Molecular Virology and Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, United States of America.
Sara LustigmanLaboratory of Molecular Parasitology, Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY, United States of America.ORCID 0000-0003-2389-6113
Thomas R KleiDepartment of Pathobiological Sciences, LSU School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA, United States of America.
Baylor College of Medicine · USLouisiana State University · USNew York Blood Center · USNational Institute of Allergy and Infectious Diseases · USUniversity of Glasgow · GBUniversity of Liverpool · GB

Funding

The development of a recombinant vaccine against human onchocerciasisR01AI078314 · NIAID · NEW YORK BLOOD CENTER · PI LUSTIGMAN, SARA · 2009 to 2021
$7.0M
Medical Research Council MR/M009114/1NIAID NIH HHS R01 AI078314Wellcome Trust 083625
6 · The paper itself

Abstract

Parasitic nematodes produce an unusual class of fatty acid and retinol (FAR)-binding proteins that may scavenge host fatty acids and retinoids. Two FARs from Brugia malayi (Bm-FAR-1 and Bm-FAR-2) were expressed as recombinant proteins, and their ligand binding, structural characteristics, and immunogenicities examined. Circular dichroism showed that rBm-FAR-1 and rBm-FAR-2 are similarly rich in α-helix structure. Unexpectedly, however, their lipid binding activities were found to be readily differentiated. Both FARs bound retinol and cis-parinaric acid similarly, but, while rBm-FAR-1 induced a dramatic increase in fluorescence emission and blue shift in peak emission by the fluorophore-tagged fatty acid (dansyl-undecanoic acid), rBm-FAR-2 did not. Recombinant forms of the related proteins from Onchocerca volvulus, rOv-FAR-1 and rOv-FAR-2, were found to be similarly distinguishable. This is the first FAR-2 protein from parasitic nematodes that is being characterized. The relative protein abundance of Bm-FAR-1 was higher than Bm-FAR-2 in the lysates of different developmental stages of B. malayi. Both FAR proteins were targets of strong IgG1, IgG3 and IgE antibody in infected individuals and individuals who were classified as endemic normal or putatively immune. In a B. malayi infection model in gerbils, immunization with rBm-FAR-1 and rBm-FAR-2 formulated in a water-in-oil-emulsion (®Montanide-720) or alum elicited high titers of antigen-specific IgG, but only gerbils immunized with rBm-FAR-1 formulated with the former produced a statistically significant reduction in adult worms (68%) following challenge with B. malayi infective larvae. These results suggest that FAR proteins may play important roles in the survival of filarial nematodes in the host, and represent potential candidates for vaccine development against lymphatic filariasis and related filarial infections.

Indexed as

Adjuvants, ImmunologicAnimalsAntibodies, HelminthAntigens, HelminthBrugia malayiCircular DichroismDisease Models, AnimalFatty Acid-Binding ProteinsFemaleFilariasisGerbillinaeHumansImmunoglobulin EImmunoglobulin GMaleParasite LoadAdjuvants, ImmunologicAntibodies, HelminthAntigens, HelminthFatty Acid-Binding ProteinsImmunoglobulin EImmunoglobulin GRetinol-Binding ProteinsVaccines, SyntheticVitamin A

Identifiers

PMID30296268
PMCPMC6193737
OpenAlexW2895504314

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.